This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: H Bion Co., Ltd.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: The Innovations of Sung-Il Roh
Introduction
Sung-Il Roh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of embryonic stem cell research. With a total of 2 patents, his work focuses on advancing medical science through innovative techniques.
Latest Patents
Sung-Il Roh's latest patents include groundbreaking developments in stem cell technology. One of his patents describes a neuro-progenitor produced from an SCNT-derived embryonic stem cell line. This line is derived from a nucleus-transferred oocyte, which is prepared by transferring a nucleus of a human somatic cell into an enucleated human oocyte. This innovative approach allows for differentiation into various desired cell types. Another patent details a human embryonic stem cell line prepared by the same nuclear transfer method, emphasizing its potential to differentiate into various cell types as well.
Career Highlights
Sung-Il Roh is associated with H Bion Co., Ltd., where he continues to push the boundaries of stem cell research. His work has garnered attention in the scientific community, contributing to advancements in regenerative medicine.
Collaborations
Some of his notable coworkers include Woo-Suk Hwang and Byeong-Chun Lee, who have also made significant contributions to the field of stem cell research.
Conclusion
Sung-Il Roh's innovative work in embryonic stem cell technology highlights his role as a key figure in advancing medical science. His patents reflect a commitment to exploring new frontiers in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile